We are live on
!
Find out more
EP
Elkhorn Partners Portfolio holdings
AUM
$157M
1-Year Est. Return
11.91%
This Fund
S&P 500
This Quarter
Est. Return
+6.88%
1 Year Est. Return
+11.91%
3 Year Est. Return
+31.51%
5 Year Est. Return
+35.62%
10 Year Est. Return
+87.18%
AUM
$146M
AUM Growth
+$7.91M
(+5.7%)
Cap. Flow
-$1M
Cap. Flow
% of AUM
-0.69%
Top 10 Holdings %
Top 10 Hldgs %
96.62%
Holding
47
New
2
Increased
14
Reduced
17
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CME Group
CME
|
+$294K |
| 2 |
KW
Kennedy-Wilson Holdings
KW
|
+$94K |
| 3 |
CRISPR Therapeutics
CRSP
|
+$71.6K |
| 4 |
Meta Platforms (Facebook)
META
|
+$35.2K |
| 5 |
Five Point Holdings
FPH
|
+$15.8K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$238K |
| 2 |
Oshkosh
OSK
|
+$232K |
| 3 |
White Mountains Insurance
WTM
|
+$217K |
| 4 |
NWLI
National Western Life Group, Inc. Class A
NWLI
|
+$149K |
| 5 |
Boeing
BA
|
+$146K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 46.7% |
| 2 | Real Estate | 45.5% |
| 3 | Communication Services | 2.99% |
| 4 | Technology | 1.43% |
| 5 | Materials | 0.85% |
Similar funds
AC
SF
BRWM
SR
HEM
CF
IWM
LW
Elkhorn Partners's Q4 2022 Portfolio in Review
As of Q4 2022, Elkhorn Partners held 47 positions worth $146M, up 5.7% from $138M the previous quarter. Its ten largest holdings account for 97% of the portfolio.
Elkhorn Partners's Q4 2022 filing shows 2 new, 14 increased, 17 reduced and 5 closed positions. Its largest new stake was CRISPR Therapeutics: 1,350 shares worth $55K. The largest sale was Berkshire Hathaway Class B, an estimated $238K.
By sector, the portfolio is most concentrated in Financials at 47% of assets, up from 44% a quarter earlier, followed by Real Estate and Communication Services.
- Elkhorn Partners's largest Q4 2022 buy was CRISPR Therapeutics: 1,350 shares worth $55K.
- Elkhorn Partners added most to CME Group in Q4 2022, an estimated $294K increase.
- Elkhorn Partners's biggest Q4 2022 reduction was Berkshire Hathaway Class B, cutting an estimated $238K.
- Elkhorn Partners fully exited Viatris in Q4 2022, selling an estimated $72K.
- Elkhorn Partners's ten largest holdings make up 97% of its $146M portfolio in Q4 2022.
- Elkhorn Partners opened 2 new positions and closed 5 in Q4 2022.
- Elkhorn Partners's portfolio value rose 5.7% quarter-over-quarter to $146M.
Based on Elkhorn Partners's 13F filing for Q4 2022, filed 14 Feb 2023.